Literature DB >> 12936995

New Klebsiella oxytoca beta-lactamase genes bla(OXY-3) and bla(OXY-4) and a third genetic group of K oxytoca based on bla(OXY-3).

Sophie A Granier1, Véronique Leflon-Guibout, Fred W Goldstein, Marie-Hélène Nicolas-Chanoine.   

Abstract

The two genetic groups (oxy-1 and oxy-2) previously identified in the Klebsiella oxytoca taxon are recognizable by four independent molecular markers: (i). ERIC-1R profiles, (ii). 16S ribosomal DNA (rDNA) signature sequences, (iii). singular nucleotides in a defined fragment of the rpoB gene, and (iv) the type of the strain's bla(OXY) gene (i.e., bla(OXY-1) or bla(OXY-2)). K. oxytoca strains SG266 and SG271 could not be classified into these genetic groups based on their ERIC-1R profile and bla(OXY) gene sequence. With regard to the gene identity percentages between the bla(OXY-1) and bla(OXY-2) gene groups (86.8% +/- 0.4%) and within a bla(OXY) gene group (>99%), it was concluded that the bla(OXY) gene of strain SG271 was representative of a new bla(OXY) gene group (bla(OXY-3)), since the mean identity percentages between it and the two bla(OXY) gene groups were 85.5% +/- 0.2% and 84.4% +/- 0.4%, respectively. Since the corresponding percentages were 95.0% +/- 0.4% and 86.2% +/- 0.3% for strain SG266, it was impossible to classify its bla(OXY) gene, which was therefore named bla(OXY-4). The 16S rDNA signature sequences of the two strains could be determined only after cloning experiments. The SG266 clones displayed the same signature sequence as that of the genetic group oxy-1, whereas the SG271 clones displayed three different 16S rDNA signature sequences that also differed from those of the two genetic groups. Singular nucleotides were found within the rpoB sequence of the two strains, allowing for their distinction from the two genetic groups. All of these results, combined with those previously obtained by the ERIC-1R PCR method, indicate that strain SG271 is representative of a new K. oxytoca genetic group (oxy-3), whereas strain SG266 could not be classified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12936995      PMCID: PMC182611          DOI: 10.1128/AAC.47.9.2922-2928.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  The extended-spectrum K1 beta-lactamase from Klebsiella oxytoca SC 10,436 is a member of the bla(OXY-2) family of chromosomal Klebsiella enzymes.

Authors:  Sophie A Granier; Véronique Leflon-Guibout; Marie-Hélène Nicolas-Chanoine; Karen Bush; Fred W Goldstein
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003.

Authors: 
Journal:  Int J Antimicrob Agents       Date:  2003-04       Impact factor: 5.283

3.  Enterobacterial repetitive intergenic consensus 1R PCR assay for detection of Raoultella sp. isolates among strains identified as Klebsiella oxytoca in the clinical laboratory.

Authors:  Sophie A Granier; Véronique Leflon-Guibout; Fred W Goldstein; Marie-Hélène Nicolas-Chanoine
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping.

Authors:  S Brisse; J Verhoef
Journal:  Int J Syst Evol Microbiol       Date:  2001-05       Impact factor: 2.747

5.  Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli.

Authors:  J Brosius; M L Palmer; P J Kennedy; H F Noller
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Optimal alignments in linear space.

Authors:  E W Myers; W Miller
Journal:  Comput Appl Biosci       Date:  1988-03

7.  Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France.

Authors:  J Sirot; M H Nicolas-Chanoine; H Chardon; J L Avril; C Cattoen; J C Croix; H Dabernat; T Fosse; J C Ghnassia; E Lecaillon; A Marmonier; M Roussel-Delvallez; C J Soussy; A Trevoux; F Vandenesch; C Dib; N Moniot-Ville; Y Rezvani
Journal:  Clin Microbiol Infect       Date:  2002-04       Impact factor: 8.067

8.  Distinct types of rRNA operons exist in the genome of the actinomycete Thermomonospora chromogena and evidence for horizontal transfer of an entire rRNA operon.

Authors:  W H Yap; Z Zhang; Y Wang
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

9.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

10.  Recognition of two genetic groups in the Klebsiella oxytoca taxon on the basis of chromosomal beta-lactamase and housekeeping gene sequences as well as ERIC-1 R PCR typing.

Authors:  Sophie A Granier; Laetitia Plaisance; Véronique Leflon-Guibout; Evelyne Lagier; Serge Morand; Fred W Goldstein; Marie-Hélène Nicolas-Chanoine
Journal:  Int J Syst Evol Microbiol       Date:  2003-05       Impact factor: 2.747

View more
  8 in total

1.  Retrospective analysis of the genetic diversity of Klebsiella oxytoca isolated in Poland over a 50-year period.

Authors:  K Stojowska; B Krawczyk; S Kałuzewski; J Kur
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-28       Impact factor: 3.267

2.  Six groups of the OXY beta-Lactamase evolved over millions of years in Klebsiella oxytoca.

Authors:  Cindy Fevre; Mehdi Jbel; Virginie Passet; François-Xavier Weill; Patrick A D Grimont; Sylvain Brisse
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Diversity and evolution of the class A chromosomal beta-lactamase gene in Klebsiella pneumoniae.

Authors:  S Haeggman; S Löfdahl; A Paauw; J Verhoef; S Brisse
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

4.  Unusual carbapenem resistant but ceftriaxone and cefepime susceptible Klebsiella oxytoca isolated from a blood culture: Case report and whole-genome sequencing investigation.

Authors:  Shangxin Yang; Peera Hemarajata; Laura Shevy; Mario Maciariello; Karissa Culbreath; Karen Bush; Romney Humphries
Journal:  IDCases       Date:  2017-11-23

5.  Description of Klebsiella spallanzanii sp. nov. and of Klebsiella pasteurii sp. nov.

Authors:  Cristina Merla; Carla Rodrigues; Virginie Passet; Marta Corbella; Harry A Thorpe; Teemu V S Kallonen; Zhiyong Zong; Piero Marone; Claudio Bandi; Davide Sassera; Jukka Corander; Edward J Feil; Sylvain Brisse
Journal:  Front Microbiol       Date:  2019-10-25       Impact factor: 5.640

6.  Whole-genome sequence-informed MALDI-TOF MS diagnostics reveal importance of Klebsiella oxytoca group in invasive infections: a retrospective clinical study.

Authors:  Aline Cuénod; Daniel Wüthrich; Helena M B Seth-Smith; Chantal Ott; Christian Gehringer; Frédéric Foucault; Roxanne Mouchet; Ali Kassim; Gunturu Revathi; Deborah R Vogt; Stefanie von Felten; Stefano Bassetti; Sarah Tschudin-Sutter; Timm Hettich; Götz Schlotterbeck; Christina Homberger; Carlo Casanova; Jacob Moran-Gilad; Orli Sagi; Belén Rodríguez-Sánchez; Franco Müller; Martina Aerni; Valeria Gaia; Helke van Dessel; Greetje A Kampinga; Claudia Müller; Claudia Daubenberger; Valentin Pflüger; Adrian Egli
Journal:  Genome Med       Date:  2021-09-13       Impact factor: 11.117

7.  Molecular identification of CTX-M and blaOXY/K1 beta-lactamase genes in Enterobacteriaceae by sequencing of universal M13-sequence tagged PCR-amplicons.

Authors:  Hans-Jürg Monstein; Maria Tärnberg; Lennart E Nilsson
Journal:  BMC Infect Dis       Date:  2009-01-22       Impact factor: 3.090

8.  Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.

Authors:  Ai Fujita; Kouji Kimura; Satoru Yokoyama; Wanchun Jin; Jun-Ichi Wachino; Keiko Yamada; Hiroyuki Suematsu; Yuka Yamagishi; Hiroshige Mikamo; Yoshichika Arakawa
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.